Founding offer · lifetime membership for a single £24, exclusive to our first members · closes 20 June Claim your place →
Global Research Partnerships £24 Lifetime Log inCreate free account

Funded Projects › H2020

FIBERSTAR · FIBER-optic sensors for Smart Thermal Ablation at Radiofrequency

H2020Status: TERMINATED1 September 201631 August 2018EU funding €158,122Call H2020-MSCA-IF-2014

FIBERSTAR is a multidisciplinary project aimed at the development of point-of-care optical fiber sensors to support non-invasive radiofrequency thermal ablation (RFTA) of tumors.RFTA is an interventional medical procedure that brings tumor cells to mortality by generating a spatially selective high-temperature field, localized within the tumor, using a percutaneous ablation device. RFTA provides ablation up to 5 cm size in hard tissues (kidney, lung), while ablation size is limited to 3 cm in liver; on the other hand, the miniature ablation device ensures a non-invasive outpatient treatment.In clinical procedures, RFTA is an image-guided procedure, which limits its efficiency. The possibility to install miniature, biocompatible, and quasi-distributed fiber-optic sensors on RFTA device, returning real-time biophysical data, can disrupt RFTA procedure. The applicant has carried out significant groundwork in the application of optical fiber sensors to ex-vivo thermal ablation on porcine liver phantoms.Building on groundwork, FIBERSTAR aims at the development of innovative fiber-optic sensors that aim at solving the main limitations of RFTA. Research addresses the development of (1) a sensor embedding pressure and distributed temperature on a single fiber, to be installed on the RFTA device, (2) a sensor for positioning RFTA device in tumor, (3) miniature quasi-distributed temperature sensors to detect the approaching of the ablation.FIBERSTAR aims at building four-fold impact:1) Implement and demonstrate smart-RFTA, whereas real-time sensors data are used to drive the RFTA treatment in close-loop complementing imaging data.2) Extend RFTA to safe treatment of prostatic and pancreatic tumors, using sensors to protect key organs from ablation.3) Provide disruptive improvement of treatment of encapsulated tumors, implementing pressure detection.4) Provide a quantified improvement of RFTA outcome in terms of reduction of failure rate and predictability.

Consortium · 1 organisation

coordinator

UNIVERSIDAD CARLOS III DE MADRID

ES · €158,122

Research fields

View the official record on CORDIS →

← Find collaborators and more funded projects

Source: CORDIS, Publications Office of the European Union. Global Research Partnerships surfaces open EU research data to help you find collaborators; we are not affiliated with the European Union.